跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPIKEVAX 2023-2024 FORMULA (XBB.1.5) SUSPENSION FOR INJECTION COVID-19 MRNA VACCINE 250 MICROGRAMS/2.5ML - PPB Drug Approval Details
Approvals
/
PPB
/
SPIKEVAX 2023-2024 FORMULA (XBB.1.5) SUSPENSION FOR INJECTION COVID-19 MRNA VACCINE 250 MICROGRAMS/2.5ML
Approved
STANDARD
SPIKEVAX 2023-2024 FORMULA (XBB.1.5) SUSPENSION FOR INJECTION COVID-19 MRNA VACCINE 250 MICROGRAMS/2.5ML
MODERNA HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
d3c05cf682f357cc
Company
MODERNA HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
d3c05cf682f357cc
Product Name
SPIKEVAX 2023-2024 FORMULA (XBB.1.5) SUSPENSION FOR INJECTION COVID-19 MRNA VACCINE 250 MICROGRAMS/2.5ML
Drug Hk Name
SPIKEVAX 2023-2024 FORMULA (XBB.1.5) SUSPENSION FOR INJECTION COVID-19 MRNA VACCINE 250 MICROGRAMS/2.5ML
Registration Code
HK-68127
Company Name
MODERNA HONG KONG LIMITED
Company Detail Path
/organization/moderna-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2024-02-22
Company Address
11/F, ONE PACIFIC PLACE, 88, QUEENSWAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
d3c05cf682f357cc
Type
Standard
Back to PPB Approvals